IL-1β levels were also elevated in patients with HNSCC, with a mean value of 12.4 ± 4.3 pg/mL, compared to 3.6 ± 1.2 pg/mL in healthy controls, indicating a highly statistically significant difference (p < 0.0001). The gene discussed is IL1B; the disease is head and neck squamous cell carcinoma.